Our goal is to investigate and assess serum cystatin-C and urinary HO-1 in the early diagnosis of renal injury (as biomarkers of renal dysfunction) and its association with ACE I/D and G2350A genotypes in T2DM patients. This evidence concerns the gene CST3 and type 2 diabetes mellitus.